Vitamin D, obesity and risk of diabetes
Abstract
Vitamin D deficiency is on the increase all over the world. The clinical role of vitamin D in calcium and bone metabolism is well known, but lower levels of the vitamin are also linked to obesity and an increased risk of developing cardiovascular disease, type 2 diabetes, and cancer. The molecular mechanisms of these associations are only partially understood, but it is known that vitamin D stimulates lipolysis and inhibits adipogenesis in human adipocytes, and lower vitamin D may induce body fat accumulation. Vitamin D receptors are expressed in pancreatic beta cells and skeletal muscle cells, and their activation results in increased insulin release and responsiveness to insulin for glucose transport. Vitamin D has recently been found to have potent antiproliferative, prodifferentiative, and immunomodulatory effects in many tissues. Vitamin D deficiency is often missed clinically even though its measurement is a simple laboratory test and its treatment is inexpensive and usually well tolerated. Nevertheless, physicians are not sufficiently informed about the effects of vitamin D other than those on the skeletal metabolism, and they rarely ask for plasma vitamin D measurement. The purpose of this review is to examine the association between vitamin D deficiency, obesity, and the risk of type 2 diabetes.
Autore Pugliese
Tutti gli autori
-
DE PERGOLA G.
Titolo volume/Rivista
Non Disponibile
Anno di pubblicazione
2012
ISSN
1828-6232
ISBN
Non Disponibile
Numero di citazioni Wos
Nessuna citazione
Ultimo Aggiornamento Citazioni
Non Disponibile
Numero di citazioni Scopus
Non Disponibile
Ultimo Aggiornamento Citazioni
Non Disponibile
Settori ERC
Non Disponibile
Codici ASJC
Non Disponibile
Condividi questo sito sui social